Author Details

Тепляков, А Т

Issue Section Title File
Vol 79, No 9 (2004) Editorial Effects of carvedilol, atenolol and their combination with fosinopril on cardiac rhythm variability, clinicofunctional status and quality of life in patients with postinfarction left ventricular dysfunction
Vol 80, No 12 (2008) Editorial Clinico-immunological disorders in patients with ischemic heart disease and metabolic syndrome: correction with nebivolol
Vol 81, No 2 (2009) Editorial Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus
Vol 81, No 3 (2009) Editorial Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
Vol 81, No 5 (2009) Editorial Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study
Vol 84, No 12 (2012) Editorial Quality of life in patients with coronary heart disease associated with metabolic syndrome: Results of factor analysis
Vol 85, No 1 (2013) Editorial Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure
Vol 85, No 5 (2013) Editorial Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome
Vol 87, No 4 (2015) Editorial Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure
Vol 88, No 9 (2016) Editorial Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies